furosemide has been researched along with lidocaine in 59 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (33.90) | 18.7374 |
1990's | 5 (8.47) | 18.2507 |
2000's | 19 (32.20) | 29.6817 |
2010's | 14 (23.73) | 24.3611 |
2020's | 1 (1.69) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Doman, TN; McGovern, SL; Seidler, J; Shoichet, BK | 1 |
Caron, G; Ermondi, G | 1 |
Jolivette, LJ; Ward, KW | 1 |
Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Conradi, R; Lee, PH; Shanmugasundaram, V | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hollander, CS; Tai, HH | 1 |
Tilley, LP; Weitz, J | 1 |
Anderson, PA; Benson, DW; Edwards, SB; Serwer, GA; Spach, M | 1 |
Bailie, MD; Hook, JB; Osborn, JL | 1 |
Bailey, B; du Souich, P; Gariépy, L; Larose, P | 1 |
Ford, E; Novick, AC; Schulak, JA; Sharp, WV | 1 |
Mehmel, HC | 1 |
Richling, B | 1 |
Botta, SA; Goodwin, HH; Straith, RE | 1 |
Appell, LH; Blythe, LL; Craig, AM; Slizeski, ML | 1 |
Adams, W; Oliver, MF; Strange, RC; Vetter, NJ | 1 |
Adgey, AA; Geddes, JS; Pantridge, JF | 1 |
Scheidler, K; Weser, C | 1 |
Agrawal, BV; Edin, H; Singh, RB; Vaish, SK | 1 |
Farber, HI | 1 |
Conn, RD | 1 |
Bleifeld, W; Hamm, CW; Kupper, W | 1 |
Bussmann, WD; Grüngras, M; Seher, W | 1 |
Dirschinger, J; Rudoph, W | 1 |
D'Arcy, PF | 1 |
Zenk, KE | 1 |
Chen, ML; Chiou, WL; Lam, G; Lee, MG | 1 |
DiBona, GF; Petersen, JS | 1 |
Church, DB; Watson, AD | 1 |
Coates, N; Gilliland, MD | 1 |
Helfrich, U; Liu, J; Maleck, W; Petroianu, G; Rüfer, R | 1 |
Alexander, KS; Fink, JM; Honisko, ME; Mauro, VF; Militello, MA | 1 |
Kim, DW; Suh, JK; Yi, HJ | 1 |
Kamono, M; Komatsu, R; Miyazaki, K; Onuma, Y | 1 |
4 review(s) available for furosemide and lidocaine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacologic and other forms of medical therapy in feline cardiac disease.
Topics: Animals; Cardiomyopathies; Cat Diseases; Cats; Diet, Sodium-Restricted; Digoxin; Electrocardiography; Furosemide; Heart Diseases; Heart Failure; Lidocaine; Propranolol; Thromboembolism | 1977 |
[Current status of treatment of the cerebral edema].
Topics: Adrenal Cortex Hormones; Barbiturates; Bed Conversion; Brain Edema; Carbon Dioxide; Combined Modality Therapy; Furosemide; Humans; Intracranial Pressure; Lidocaine; Mannitol; Osmolar Concentration; Sorbitol; Stroke Volume; Tromethamine | 1987 |
An overview of perinatal clinical pharmacology.
Topics: Abnormalities, Drug-Induced; Analgesics; Bupivacaine; Carbamazepine; Chloramphenicol; Diazepam; Digoxin; Female; Fetus; Furosemide; Gentamicins; Humans; Indomethacin; Infant, Newborn; Infant, Newborn, Diseases; Lidocaine; Penicillins; Phenobarbital; Phenytoin; Pregnancy; Pregnancy Complications; Tetracycline; Theophylline | 1981 |
1 trial(s) available for furosemide and lidocaine
Article | Year |
---|---|
[Reduction in CK- and CKMB-measured infarct size by verapamil].
Topics: Blood Pressure; Creatine Kinase; Dose-Response Relationship, Drug; Furosemide; Heart Block; Heart Rate; Humans; Isoenzymes; Lidocaine; Myocardial Infarction; Nitroglycerin; Verapamil | 1983 |
54 other study(ies) available for furosemide and lidocaine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Topics: Antifungal Agents; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Molecular; Molecular Conformation; Scattering, Radiation; Structure-Activity Relationship | 2003 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics | 2005 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Molecular characteristics for solid-state limited solubility.
Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.
Topics: 1-Methyl-3-isobutylxanthine; Cell Line; Cell Membrane Permeability; Humans; Models, Biological; Quantitative Structure-Activity Relationship; Skin Absorption | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Kinetic evidence of a distinct regulatory site on 15-hydroxyprostaglandin dehydrogenase.
Topics: Alcohol Oxidoreductases; Allosteric Regulation; Allosteric Site; Animals; Enzyme Activation; Ethacrynic Acid; Furosemide; Hydroxyprostaglandin Dehydrogenases; Imipramine; Kidney; Kinetics; Lidocaine; NAD; Prostaglandins E; Swine | 1976 |
Ventricular tachyarrhythmia due to cardiac sarcoidosis in a child.
Topics: Cardiomyopathies; Child; Electrocardiography; Female; Furosemide; Heart Failure; Heart Ventricles; Humans; Lidocaine; Prednisone; Quinidine; Sarcoidosis; Tachycardia | 1978 |
Control of renin release. Effects of d-propranolol and renal denervation on furosemide-induced renin release in the dog.
Topics: Animals; Denervation; Dogs; Furosemide; Ischemia; Kidney; Lidocaine; Male; Propranolol; Renin; Stereoisomerism | 1977 |
Effect of lignocaine on arginine-vasopressin plasma levels: baseline or induced by frusemide.
Topics: Animals; Arginine Vasopressin; Diuresis; Furosemide; In Vitro Techniques; Indocyanine Green; Lidocaine; Liver Circulation; Liver Function Tests; Male; Rabbits | 1992 |
Donor pretreatment with lidocaine decreases incidence of early renal dysfunction in cadaver kidney transplantation.
Topics: Blood Urea Nitrogen; Brain Death; Cadaver; Creatinine; Furosemide; Heparin; Humans; Kidney Transplantation; Lidocaine; Mannitol; Methylprednisolone; Tissue Donors | 1990 |
[Therapy of acute myocardial infarct].
Topics: Acidosis; Analgesics; Atropine; Bicarbonates; Bradycardia; Cardiac Complexes, Premature; Critical Care; Diazepam; Digitalis Glycosides; Early Ambulation; First Aid; Furosemide; Heparin; Humans; Hypertension; Lidocaine; Myocardial Infarction; Nitroglycerin; Pacemaker, Artificial; Positive-Pressure Respiration; Sodium; Sodium Bicarbonate; Verapamil | 1985 |
Cardiac arrhythmias in phenol face peeling: a suggested protocol for prevention.
Topics: Arrhythmias, Cardiac; Chemexfoliation; Diuresis; Fluid Therapy; Furosemide; Humans; Lidocaine; Monitoring, Physiologic; Phenols; Time Factors | 1988 |
Evaluation of the potential for interference by dimethyl sulfoxide (DMSO) in drug detection in racing animals.
Topics: Acepromazine; Animals; Apomorphine; Caffeine; Chromatography, Thin Layer; Clonixin; Cocaine; Dimethyl Sulfoxide; Drug Interactions; Female; Furosemide; Horses; Lidocaine; Pharmaceutical Preparations; Phenylbutazone | 1987 |
Initial metabolic and hormonal response to acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Blood Glucose; Blood Specimen Collection; Catecholamines; Cholesterol; Cyclic AMP; Cyclizine; Diazepam; Digoxin; Fatty Acids, Nonesterified; Female; Furosemide; Humans; Hydrocortisone; Insulin; Lidocaine; Lipids; Male; Middle Aged; Morphine; Myocardial Infarction; Myocardium; Time Factors; Triglycerides | 1974 |
Prognosis after recovery from ventricular fibrillation complicating ischaemic heart-disease.
Topics: Anti-Bacterial Agents; Anticoagulants; Female; Follow-Up Studies; Furosemide; Glucose; Heart Arrest; Humans; Insulin; Ischemia; Lidocaine; Male; Middle Aged; Myocardial Infarction; Potassium; Procainamide; Prognosis; Resuscitation; Ventricular Fibrillation | 1967 |
[Differential treatment of coronary heart disease].
Topics: Angina Pectoris; Aspirin; Cardiac Glycosides; Coronary Disease; Dipyridamole; Furosemide; Heparin; Humans; Lidocaine; Methods; Myocardial Infarction; Nitroglycerin; Pentaerythritol Tetranitrate; Prenylamine; Propranolol | 1974 |
Cardiac asystole due to lignocaine in a patient with digitalis toxicity.
Topics: Arrhythmias, Cardiac; Digoxin; Female; Furosemide; Heart Arrest; Heart Failure; Humans; Lidocaine; Middle Aged | 1974 |
Fever, vomiting, and liver dysfunction with procainamide therapy.
Topics: Ampicillin; Blood; Chemical and Drug Induced Liver Injury; Digitalis; Drug Hypersensitivity; Female; Fever; Furosemide; Humans; Lidocaine; Middle Aged; Myocardial Infarction; Phytotherapy; Plants, Medicinal; Plants, Toxic; Procainamide; Quinidine; Urine; Vomiting | 1974 |
New drugs for old hearts. Newer antiarrhythmic and diuretic agents.
Topics: Aged; Anti-Arrhythmia Agents; Diuretics; Ethacrynic Acid; Female; Furosemide; Humans; Lidocaine; Male; Phenytoin; Propranolol | 1967 |
[Therapy of acute myocardial infarct before hospital admission].
Topics: Aged; Atropine; Bradycardia; Cardiac Complexes, Premature; Diagnosis, Differential; First Aid; Furosemide; Heart Failure; Hemodynamics; Humans; Hypertension; Lidocaine; Myocardial Infarction; Nitroglycerin | 1982 |
[The immediate treatment of acute myocardial infarct].
Topics: Acute Disease; Arrhythmias, Cardiac; First Aid; Furosemide; Hemodynamics; Humans; Isosorbide Dinitrate; Lidocaine; Myocardial Infarction; Nitroglycerin; Oxygen Inhalation Therapy; Pain; Shock, Cardiogenic | 1981 |
Early reports on drug interactions.
Topics: Acetaminophen; Amiodarone; Apazone; Aspirin; Carbamazepine; Chlordiazepoxide; Cimetidine; Coumarins; Drug Interactions; Erythromycin; Ethanol; Furosemide; Gentamicins; Humans; Levodopa; Lidocaine; Phenytoin; Prenylamine; Quinidine | 1983 |
Arterial-venous plasma concentration differences of six drugs in the dog and rabbit after intravenous administration.
Topics: Animals; Arteries; Dogs; Furosemide; Griseofulvin; Injections, Intravenous; Kinetics; Lidocaine; Male; Pharmaceutical Preparations; Procainamide; Propranolol; Rabbits; Theophylline; Veins | 1981 |
Furosemide elicits nonuniform reflex responses via cardiac sympathetic afferents.
Topics: Animals; Blood Pressure; Denervation; Dose-Response Relationship, Drug; Furosemide; Heart Conduction System; Indomethacin; Injections; Lidocaine; Male; Neurons, Afferent; Pericardium; Rats; Rats, Sprague-Dawley; Reflex; Sympathetic Nervous System; Vagotomy | 1994 |
Preferences of veterinarians for drugs to treat heart disease in dogs and cats.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Australia; Cardiotonic Agents; Cardiovascular Agents; Cat Diseases; Cats; Digoxin; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Diseases; Heart Failure; Lidocaine; Propranolol; Surveys and Questionnaires; Vasodilator Agents | 1995 |
Tumescent liposuction complicated by pulmonary edema.
Topics: Anesthesia, Conduction; Anesthetics, Local; Diuretics; Epinephrine; Furosemide; Humans; Isotonic Solutions; Lidocaine; Lipectomy; Male; Middle Aged; Oliguria; Pulmonary Edema; Ringer's Lactate; Weight Lifting | 1997 |
Phospholipase A2-induced coagulation abnormalities after bee sting.
Topics: Animals; Antithrombin III; Bee Venoms; Bees; Blood Coagulation Disorders; Blood Coagulation Tests; Cromolyn Sodium; Drug Evaluation, Preclinical; Factor V; Factor VIII; Female; Fibrinogen; Furosemide; Humans; Insect Bites and Stings; Ketamine; Lidocaine; Linear Models; Magnesium; Male; Phospholipases A; Phospholipases A2; Prothrombin | 2000 |
Compatibility of argatroban with selected cardiovascular agents.
Topics: Amiodarone; Anticoagulants; Arginine; Cardiovascular Agents; Drug Interactions; Drug Therapy, Combination; Fenoldopam; Furosemide; Humans; Infusions, Parenteral; Lidocaine; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Pipecolic Acids; Sulfonamides; Vasopressins | 2004 |
Hypotensive shock during anesthesia for endovascular embolization.
Topics: Adrenergic Agents; Adrenergic Agonists; Aged; Anaphylaxis; Anesthesia; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Contrast Media; Diuretics; Drug Interactions; Embolization, Therapeutic; Ephedrine; Epinephrine; Furosemide; Humans; Hypotension; Intubation, Intratracheal; Lidocaine; Male; Subarachnoid Hemorrhage; Triiodobenzoic Acids; Ventricular Premature Complexes | 2008 |
Development of Pulmonary Edema Despite Negative Fluid Balance with Diuretics in a Patient with Heart Failure and Sigmoid Septum.
Topics: Aged, 80 and over; Diuretics; Furosemide; Heart Failure; Humans; Lidocaine; Male; Pulmonary Edema; Ventricular Outflow Obstruction; Ventricular Septum | 2020 |